The prenatal test that thoroughly investigates the health status of the baby and their DNA during pregnancy.
Prenatalscreen® analyses more than 1,000 genetic diseases with a single sample. A comprehensive and sophisticated test for your baby’s safety.
The prenatal test that thoroughly investigates the health status of the baby and their DNA during pregnancy.
Prenatalscreen® analyses more than 1,000 genetic diseases with a single sample. A comprehensive and sophisticated test for your baby’s safety.
Prenatal genetic tests
Prenatal genetic tests are tests performed during pregnancy to assess the health status of the child.
Indeed, these tests allow early detection of diseases associated with DNA variants and numerical and structural chromosome aberrations.
Being informed is the first step to obtaining assistance in childbirth or to initiating, when possible, a course of treatment before or immediately after the birth of the child.
Prenatalscreen®, the extensive prenatal test for detecting chromosomal abnormalities and various genetic diseases directly on the fetus, is the result of Eurofins Genoma’s OrizzonteNascita project.
Prenatalscreen® is a state-of-the-art invasive prenatal test on amniotic fluid collected through amniocentesis (AC), or on placental tissue collected through chorionic villus sampling (CVS). With a single sample, it is possible to analyze over 1,000 genetic diseases of the fetus, including the most common in the Italian population such as Cystic Fibrosis, Sickle Cell Anaemia, Beta Thalassaemia, Spinal Muscular Atrophy and Hereditary Deafness.
Who we recommend Prenatalscreen® for
Those who have personal or family history of hereditary genetic diseases
Those who wish to diagnose genetic diseases in the fetus early on.
For all pregnancies obtained through natural conception or medically assisted reproduction (MAR)
For couples who have used heterologous fertilization techniques.
In case of ultrasound doubts that may indicate a genetic disease
How is it performed?
Prenatalscreen® on chorionic villi is performed through abdominal retrieval of chorionic villi between the 11th and 13th weeks of pregnancy.
Prenatalscreen® on amniotic fluid is performed through abdominal retrieval of amniotic fluid between the 15th and 18th weeks of pregnancy.
Provides two levels:
Focus
It is a test that allows the analysis of 31 genetic diseases including the most common ones in the Italian population, such as cystic fibrosis, sickle cell anemia, thalassemia, and hereditary deafness.
Standard
It is a test that allows the study of a large number of genes and over 1,000 genetic diseases, including the most common ones in the Italian population and clinically more relevant.